VONOPRAZAN, A NOVEL ACTIVE POTASSIUM-COMPETITIVE ACID BLOCKER, AND RABEPRAZOLE INDUCE SMALL INTESTINAL DYSBIOSIS AND EXACERBATE THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED SMALL INTESTINAL ENTEROPATHY

(1) Osaka City University Graduate School of Medicine Dept. of Gastroenterology,Dept. of Gastroenterology,Osaka,Japan

(2) Osaka City University,Dept. of Gastroenterology,Osaka,Japan



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)